Article
Genetic justification of severe COVID-19 using a rigorous algorithm.
Clinical immunology (Orlando, Fla.) - 1 May 2021
Gavriilaki Eleni, Asteris Panagiotis G, Touloumenidou Tasoula, Koravou Evaggelia-Evdoxia, Koutra Maria, Papayanni Penelope Georgia, Karali Vassiliki, Papalexandri Apostolia, Varelas Christos, Chatzopoulou Fani, Chatzidimitriou Maria, Chatzidimitriou Dimitrios, Veleni Anastasia, Grigoriadis Savvas, Rapti Evdoxia, Chloros Diamantis, Kioumis Ioannis, Kaimakamis Evaggelos, Bitzani Milly, Boumpas Dimitrios, Tsantes Argyris, Sotiropoulos Damianos, Sakellari Ioanna, Kalantzis Ioannis G, Parastatidis Stefanos T, Koopialipoor Mohammadreza, Cavaleri Liborio, Armaghani Danial J, Papadopoulou Anastasia, Brodsky Robert Alan, Kokoris Styliani, Anagnostopoulos Achilles
Abstract excerpt
Recent studies suggest excessive complement activation in severe coronavirus disease-19 (COVID-19). The latter shares common characteristics with complement-mediated thrombotic microangiopathy (TMA). We hypothesized that genetic susceptibility would be evident in patients with severe COVID-19 (similar to TMA) and associated with disease severity. We analyzed genetic and clinical data from 97 patients hospitalized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
